Monday, February 10, 2020 to Wednesday, February 12, 2020
Sheraton Grand Phoenix Hotel, Phoenix, Arizona
Wilentz attorneys Michael F. Schaff and Lisa Gora will each present at the American Health Lawyers Association’s Physicians and Hospitals Law Institute.
During a presentation entitled “Take Two Aspirin and Call Me in the Morning: A Prescription for Ethical Representation of Physicians and/or Physician Organizations,” Mr. Schaff will discuss ethics in representing physicians, including considerations on the attorney-client relationship, the applicability of the Advice-of-Counsel defense, and the impacts of the Yates Memo on an organization’s leadership. Ms. Gora will present “The Past, the Present, the Future regarding Hemp, Medical and Recreational Cannabis, and the Myriad of Issues that Attorneys Should be Aware,” broadening the conversation on the legal implications of medical marijuana, hemp and hemp-based CBD for physicians and physician organizations given the tension between state and federal laws.
The annual Institute offers in-depth breakout sessions focusing on legal challenges faced by physicians, hospitals, health systems, and their counsel. Other topics covered by the program include physician self-referral regulations, physician arrangements, compliance, gainsharing and co-management, and value-based programs.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.